Pall Buys Chromatography Business
EAST HILLS, N.Y., Dec. 2 -- Pall Corp. announced Tuesday it has completed the acquisition of the BioSepra Process Division from Ciphergen Biosystems Inc., of Fremont, Calif. The purchase price was $32 million, net of cash and debt. The BioSepra Process Division develops, manufactures and markets chromatography sorbents used in protein purification for drug development and production.
Pall and Ciphergen have also entered into a collaboration for process proteomics, based on the combination of Ciphergen's ProteinChip technology and BioSepra's chromatography products.
Pall makes filtration, separations and purification technology for life sciences and industrial markets, including biotechnology, pharmaceutical, transfusion medicine, semiconductor, water purification and aerospace applications.
For more information, visit: www.pall.com
LATEST NEWS
- CLEO Heads to the East Coast
Apr 29, 2024
- Laser-Based Gas Analyzer Developed to Detect Air Pollution
Apr 29, 2024
- Qubits Could be Stored in Flash-Like Memory
Apr 29, 2024
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024